London open: Asian data lifts stocks early on
2nd Jul 2012 08:30
- Chinese, Japanese data comes in better than expected - RBS falls on Libor issues - Barclays Chairman resigns London's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment. China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last mont
Read moreAstra expands diabetes alliance with Bristol-Myers Squibb
2nd Jul 2012 07:50
AstraZeneca (AZN) has said that it will benefit from Bristol-Myers Squibb's (BMS's) acquisition of Amylin Pharmaceuticals as it strengthens the leadership position of its diabetes alliance with BMS in a 'growing area of high unmet medical need'. US biopharmaceutical giant BMS has announced on Monda
Read moreSigns looking good in EU for Astra's Zinforo
22nd Jun 2012 15:51
Anglo-Swedish drugs developer AstraZeneca said its Zinforo skin infection treatment has been given a positive verdict by the Committee for Medicinal Products for Human Use (CHMP). The CHMP's positive opinion will now be reviewed by the European Commission, which has the authority to approve medicin
Read moreLondon open: Stocks fall on Chinese data, US growth
21st Jun 2012 08:40
- Chinese PMI falls to seven-month low - Fed extends 'the twist', lowers GDP forecast - Miners provide a drag in London Disappointing economic data from China and a downward revision to US growth dented the Footsie in early trading on Thursday, with mining stocks bearing the brunt of the sell-off.
Read moreLondon midday: Stocks gain on stimulus hopes
20th Jun 2012 11:31
- Stocks pare losses after MPC minutes - Markets await the Fed decision later today - Aviva, ITV and Sage gain; ex-div stocks drag The Bank of England's (BoE's) vote on maintaining its asset purchase programme proved to be a contentious issue last month and the news provided a boost to stock market
Read moreLondon open: Markets cautious ahead the Fed decision
20th Jun 2012 08:43
- Eyes on the MPC, Greece and FOMC - Ex-div stocks dampen Footsie - ITV gains on bid rumours The Footsie slight lower on Wednesday morning with investors showing caution ahead of what is likely to be a busy day on the macro-economic front; all eyes will be on the Bank of England (BoE), Greek leader
Read moreAstraZeneca completes Ardea takeover
20th Jun 2012 07:22
AstraZeneca said it had successfully completed its acquisition of California-based biotechnology company Ardea Biosciences. The pharmaceutical giant said the $1.2bn deal would strengthen its late-stage pipeline with the addition of lesinurad, which is aimed at patients with gout. Astra paid $32 pe
Read moreMonday newspaper round-up: Small business, Bank of Cyprus, C&W
18th Jun 2012 06:46
Small businesses are facing a new credit crunch that is denting confidence and restricting growth even as the UK government launches an 80bn pound scheme to boost lending. In research published yesterday, the Federation of Small Businesses (FSB) said banks are rejecting more than four in ten firms t
Read moreFriday newspaper round-up: Inflation, Thomas Cook, Banking
25th May 2012 06:53
David Cameron will face demands from Tory MPs to redraw Britain's relationship with Europe in the event of a Greek exit from the Eurozone, senior government sources believe. No 10 and the Foreign and Commonwealth Office say that treaties governing the European Union will have to be rewritten after t
Read moreThursday broker round-up - UPDATE
24th May 2012 09:27
ARM Holdings: Jefferies reiterates buy recommendation and 485p target. ASOS: Investec keeps hold rating and 1,250p target. AstraZeneca: AlphaValue upgrades to BUY from add. Booker: Panmure Gordon upgrades from hold to buy. Bowleven: UBS slashes target from 105p to 70p, neutral rating unchanged.
Read moreLondon midday: Stocks rise ahead of EU summit
22nd May 2012 12:00
- Miners wanted on Chinese stimulus speculation - Fitch downgrades Japanese rating - Markets await EU summit tomorrow, OECD backs eurobonds The FTSE 100 held on to its earlier gains by Tuesday lunchtime as investors look ahead to tomorrow's EU summit with optimism, as pressure builds on Eurozone l
Read moreWednesday newspaper round-up: Greece, RBS, AstraZeneca
16th May 2012 07:12
As leaders in Athens accepted the need for a new general election to end a national stalemate, the International Monetary Fund said Europe's leaders should prepare for the possibility of a Greek departure from the single currency. Christine Lagarde, head of the IMF, warned she was "technically prepa
Read moreBroker snap: With new leader, it's Astra's 'time to strike', says UBS
4th May 2012 15:15
Drugs giant AstraZeneca was added to UBS's 'Key Calls' list on Friday with the broker reiterating its buy recommendation on the stock. "With the announcement that Chief Executive Officer Brennan is retiring and new Chairman Johansson is starting on June 1st, we increasingly see the likelihood of st
Read moreFTSE 100 movers: RBS flying high on results update
4th May 2012 14:14
Nationalised lender Royal Bank of Scotland (RBS) was a high riser after its first-quarter results. The group is to repay the final tranche of notes issued under the government's Credit Guarantee Scheme (CGS) next week, after posting a profit of more than a billion pounds in the first three months of
Read moreLondon midday: Stocks lower before US non-farm payrolls
4th May 2012 12:10
- Miners drop on macro concerns, Australian growth - RBS rises after Q1 update - Markets await US non-farm payrolls The Footsie was firmly lower by Friday lunchtime as a sell-off in the mining sector outweighed a strong performance by the banks after some well-received results from Royal Bank of Sc
Read more